Profile
Peter Bollmann served as an Independent Non-Executive Director at AC Immune SA from 2015 to 2021.
He also held director positions at Prionics AG, Cytos Biotechnology AG, and Heidelberg Instruments Nano AG.
Former positions of Peter Bollmann
| Companies | Position | End |
|---|---|---|
| AC IMMUNE SA | Director/Board Member | 29/10/2021 |
Heidelberg Instruments Nano AG
Heidelberg Instruments Nano AG Information Technology ServicesTechnology Services Specializes in nanolithography technology | Director/Board Member | - |
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Develops and wholesales diagnostic solutions for farm animal diseases | Director/Board Member | - |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Develops and wholesales diagnostic solutions for farm animal diseases | Health Technology |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
Heidelberg Instruments Nano AG
Heidelberg Instruments Nano AG Information Technology ServicesTechnology Services Specializes in nanolithography technology | Technology Services |
- Stock Market
- Insiders
- Peter Bollmann
















